Older adults with multiple sclerosis (MS) show a higher prevalence and severity of cognitive impairment — particularly affecting information processing speed and memory — than younger patients, a new study reports. However, age was not directly associated with cognitive impairment, the results showed. Instead, greater disability emerged as the main predictor of such problems in…
Category: Multiple Sclerosis Research
New research findings challenge old beliefs about myelin repair in MS
Oligodendrocytes, the cells responsible for making myelin, are constantly being made throughout the brain and spinal cord, even when there’s no myelin damage, according to a new study by U.S. researchers. These findings challenge the long-held view that oligodendrocyte precursor cells mostly differentiate into oligodendrocytes at sites of damage to drive myelin repair. Instead, this…
More Noise
A new year, a new malady Did you know that “raja” is a legitimate Scrabble word? I didn’t and I’m a pretty decent Scrabble player. In fact, my friend’s niece thinks I am a Scrabble queen because I taught her about adding an s, r or d to a word and making a new word…
Making beaded curtains helps improve my fine motor skills
About two years after my multiple sclerosis (MS) diagnosis, I began having hand-related symptoms that interfered with my daily life and caused significant stress. I’m a college student and remote employee, so I spend a lot of time typing, which is considered a fine motor skill because of the coordination and precision required. The symptoms I…
Monitoring Natalizumab Post-Dosing. Is it necessary?
Tweet Natalizumab is a migration inhibitor that works because it blocks lymphocytes and monocytes from migrating into the CNS and other tissues. It has been given as an intravenous infusion and more recently, as the patent runs out, as an injection under the skin. These both used to be given in hospital, but the latter…
From our CEO
The post From our CEO appeared first on MS Australia. Source: www.msaustralia.org.au
Tolebrutinib outcomes not as hoped for progressive MS
The post Tolebrutinib outcomes not as hoped for progressive MS appeared first on MS Australia. Source: www.msaustralia.org.au
New relapsing remitting MS treatment, Briumvi®, listed on the PBS
The post New relapsing remitting MS treatment, Briumvi®, listed on the PBS appeared first on MS Australia. Source: www.msaustralia.org.au
Is it MS or something else? New research explains
The post Is it MS or something else? New research explains appeared first on MS Australia. Source: www.msaustralia.org.au
Bridging Science and Lived Experience: Reflections on the 2025 MS Progress in Research Conference
The post Bridging Science and Lived Experience: Reflections on the 2025 MS Progress in Research Conference appeared first on MS Australia. Source: www.msaustralia.org.au